CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-19 | DRISCOLL FREDERICK W Director | Purchase | +62,500 | $1.60 | $100K | 62,500 |
| 2019-12-19 | Drazba Brian G. Chief Financial Officer | Purchase | +12,500 | $1.60 | $20K | 37,500 |
| 2019-12-19 | GOLD DANIEL P PHD Chief Executive Officer | Purchase | +18,750 | $1.60 | $30K | 361,632 |
| 2019-09-27 | GOLD DANIEL P PHD Chief Executive Officer | Option exercise | +20,000 | $1.57 | $31K | 342,882 |
| 2019-09-27 | GOLD DANIEL P PHD Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −20,000 | 287,500 | ||
| 2019-09-06 | White Christine Anna Director | Purchase | +15,000 | $1.74 | $26K | 15,000 |
| 2019-07-01 | Urso David M Chief Operating Officer & GC | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2019-07-01 | Mass Robert D. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2019-07-01 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +680,000 | 680,000 | ||
| 2019-07-01 | Drazba Brian G. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2019-07-01 | White Christine Anna Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Rueckert William Dodge Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Reynolds Thomas C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Glover Nicholas Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Clemens Kevan Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | Baltic Charles V. III Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-07-01 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-08-07 | Urso David M Chief Operating Officer & GC | Sale | −9,500 | $3.58 | $34K | 24,106 |
| 2018-08-06 | GOLD DANIEL P PHD Chief Executive Officer | Shares withheld for taxes | −50,938 | $3.75 | $191K | 322,882 |
Page 7 of 13 · 252 trades